Role of BCL-2 family of proteins in malignancy

Hematological Oncology

Volumn 20, Issue 2, 2002, Pages 63-74

  Baliga, Belinda C ^a   Kumar, Sharad ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Apoptosis; Bax; Bcl 2; Bcl X; BH domains; Caspases

Indexed keywords

CASPASE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; CARCINOGENESIS; ENZYME ACTIVATION; GENE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SEQUENCE HOMOLOGY;

APOPTOSIS; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0036087028     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.685     Document Type: Review

References (89)

1. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
2. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
3. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18
4. Prevention of neuronal cell death by Bcl-2
5. Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell
6. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
7. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)
8. E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells
9. Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice
10. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
11. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
12. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
13. Role of BAX in the apoptotic response to anticancer agents
14. Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution
15. BCL-2 family members and the mitochondria in apoptosis
16. Bcl-2-family proteins: The role of the BH3 domain in apoptosis
17. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
18. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3
19. Identification of small molecule inhibitors of interaction between the BH3 domain and Bcl-xL
20. Regulated targeting of BAX to mitochondria
21. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
22. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane
23. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis
24. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex
25. How BAD phosphorylation is good for survival
26. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
27. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
28. Genetic control of programmed cell death in the nematode C elegans
29. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
30. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
31. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9
32. Debcl a proapoptotic Bcl-2 homologue, is a component of the Drosophila melanogaster cell death machinery
33. Cloning and characterization of a novel nuclear bcl-2 family protein, zfMc1-1a, in zebrafish embryo
34. An evolutionary perspective on apoptosis
35. The fight of viruses against apoptosis
36. Genetic control of programmed cell death in Drosophila
37. Cell death in the fly comes of age
38. Regulation and execution of apoptosis during Drosophila development
39. Bcl-2 and bax mammalian regulators of apoptosis are functional in drosophila
40. Apoptosis signaling
41. The ICE family of cysteine proteases as effectors of cell death
42. Caspase structure, proteolytic substrates, and function during apoptotic cell death
43. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
44. The fly caspases
45. Mechanisms mediating caspase activation in cell death
46. Prodomains-adaptors-oligomerization: The pursuit of caspase activation in apoptosis
47. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
48. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
49. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria
50. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c
51. Bax directly induces release of cytochrome c from isolated mitochondria
52. 2+ ions
53. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition
54. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-XL
55. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
56. The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol
57. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
58. Structure of bax. Coregulation of dimer formation and intracellular localization
59. Solution structure of BID, an intracellular amplifier of apoptotic signaling
60. Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists
61. Bcl-2 family proteins as ion-channels
62. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2
63. Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c
64. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells
65. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
66. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
67. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1
68. Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-x(L)
69. Injected cytochrome c induces apoptosis
70. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice
71. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
72. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice
73. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant
74. Testicular degeneration in Bclw-deficient mice
75. Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine
76. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene
77. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues
78. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
79. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
80. Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia - The role of Bcl-2 family dysregulation
81. Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease
82. Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide
83. Human Bcl-2 antisense therapy for lymphomas
84. Chemosensitisation of malignant melanoma by BCL2 antisense therapy
85. In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts
86. Expression of Bcl-2-related genes in normal and AML progenitors: Changes induced by chemotherapy and retinoic acid
87. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: A review
88. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with pin1
89. Cell permeable Bcl-2 binding peptides: A chemical approach to apoptosis induction in tumor cells